Rani Therapeutics Holdings, Inc. (RANI:NASDAQ) closed at $0.590 on October 30, 2026, down 2.54% on the day. The stock trades 77.6% below its 52-week high of $2.63 and 2.9% above its 52-week low of $0.573. Over the past year, it lost 73.2%. Rani Therapeutics Holdings, Inc. is part of the Health Care sector.
In 252 trading sessions since October 30, 2025, RANI closed higher on 109 days (43%). Its best day was October 31, 2025 (+51.72%) and its worst was March 27, 2026 (-24.91%). The stock moved 10% or more in a single session 17 times. It opened at least 5% above the previous day's high 1 time.
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.
Find more stocks like RANI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.